期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
青岛地区糖尿病视网膜病变严重程度的相关危险因素(英文) 被引量:2
1
作者 王荣荣 王德祖 +1 位作者 孙金涛 刘桂香 《国际眼科杂志》 CAS 北大核心 2018年第7期1174-1179,共6页
目的:调查和分析青岛地区糖尿病视网膜病变的发病率及其严重程度的危险因素。方法:该调查研究分两部分:调查青岛地区2859名60岁以上的社区居民和4275名30岁以上的2型糖尿病住院患者。对所有研究对象进行眼科检查,血压及糖化血红蛋白测定... 目的:调查和分析青岛地区糖尿病视网膜病变的发病率及其严重程度的危险因素。方法:该调查研究分两部分:调查青岛地区2859名60岁以上的社区居民和4275名30岁以上的2型糖尿病住院患者。对所有研究对象进行眼科检查,血压及糖化血红蛋白测定,并通过调查问卷获得其年龄,性别,糖尿病病程,血糖控制情况及他们对糖尿病视网膜病变的了解情况。对所有的糖尿病视网膜病变(DR)患者进行眼底检查并照相,按EDTR标准对DR严重程度分级。重度非增殖期及增殖期DR,有临床意义的糖尿病黄斑水肿患者均归为需治疗组;而轻中度非增殖期DR及无临床意义的糖尿病黄斑水肿均归为需观察组。对所得数据进行相关和回归分析以确定糖尿病视网膜病变的需治疗率和危险因素。Logistic回归模型用于估计调整患者年龄,性别,病程后的优势比(OR)和95%可信区间(CI)。结果:2859名60岁以上居民中有334例(11.68%)患有糖尿病视网膜病变,其中48(14.81%)名居民需治疗;4275名住院2型糖尿病患者中,1097例(25.66%)患有糖尿病视网膜病变,172(15.68%)例住院患者需要接受眼底激光或手术治疗。单变量和多变量回归分析显示,以下因素与糖尿病视网膜病变的需治疗率明显相关,包括:年龄(51~60岁:OR,1.68;95%CI:1.21~1.72;61~70岁:OR,1.55;95%CI:1.38~1.76);病程(11~15年:OR,2.61;95%CI:1.51~4.72;超过15年病程:OR,4.15;95%CI:2.32~5.77);血糖控制情况:(血糖控制一般:OR,2.51;95%CI:1.98~3.92;血糖控制差:OR,4.69;95%CI:3.39~6.95);对糖尿病视网膜病变的了解情况(完全不了解:OR,1.45;95%CI:1.21~1.95)。而性别,31~50岁及70岁以上年龄,<10年的糖尿病病程,高血压和胰岛素治疗均与DR的需治疗率无关。结论:青岛地区糖尿病视网膜病变的发病率和需治疗率较高。51~70岁年龄,超过10年的糖尿病病程,血糖控制欠佳,对糖尿病视网膜病变不了解是DR患者视网膜病变需治疗率的潜在危险因素。加强对51~70岁的2型糖尿病患者关于糖尿病视网膜病变的宣传教育,建立规范的社区糖尿病筛查系统,对早期防控DR的高发病率和致盲率至关重要。 展开更多
关键词 糖尿病视网膜病变 糖尿病 发病率 病程 年龄
下载PDF
Efficacy and safety of intravitreal ranibizumab with panretinal photocoagulation followed by trabeculectomy compared with Ahmed glaucoma valve implantation in neovascular glaucoma 被引量:14
2
作者 jin-tao sun Hai-Jing Liang +1 位作者 Meng An Da-Bo Wang 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2017年第3期400-405,共6页
AIM:To evaluate the efficacy and safety of intravitreal ranibizumab(IVR)with panretinal photocoagulation(PRP)followed by trabeculectomy compared with Ahmed glaucoma valve(AGV)implantation in neovascular glaucom... AIM:To evaluate the efficacy and safety of intravitreal ranibizumab(IVR)with panretinal photocoagulation(PRP)followed by trabeculectomy compared with Ahmed glaucoma valve(AGV)implantation in neovascular glaucoma(NVG).METHODS:This was a retrospective comparative study.We reviewed the cases of a total of 45 eyes from 45 NVG patients among which 23 eyes underwent AGV implantation and the other 22 underwent trabeculectomy. The causes of neovascular glaucoma included:diabetic retinopathy(25 eyes),and retinal vein occlusion(20 eyes).All patients received preoperative IVR combined with postoperative PRP. The mean best-corrected visual acuities(BCVA)were converted to the logarithms of the minimum angle of resolution(log MAR)for the statisitical analyses.Intraocular pressure(IOP),the log MAR BCVA and surgical complications were evaluated before and after surgery.The follow-up period was 12 mo.RESULTS:A total of 39 cases showed complete regression of iris neovascularization at 7d after injection,and 6 cases showed a small amount of residual iris neovascularization. The success rates were 81.8% and 82.6% at 12 mo after trabeculectomy and AGV implantation,respectively. In the trabeculectomy group,the log MAR BCVA improved at the last follow-up in 14 eyes,remained stable in 6 eyes and decreased in 2 eyes. In 4 cases,slight hyphemas developed after trabeculectomy. A shallow anterior chamber developed in 2 cases and 2 vitreous hemorrhages. In the AGV group,the log MAR BCVA improved in 14 eyes,remained stable in 5 eyes and decreased in 4 eyes. Slight hyphemas developed in 3 cases,and a shallow anterior chamber in 3 cases. The mean postoperative IOP was significantly lower in both groups after surgery(F=545.468,P〈0.05),and the mean postoperative log MAR BCVA was also significantly improved(F=10.964,P〈0.05)with no significant difference between two groups.CONCLUSION:It is safe and effective to treat NVG with this combined procedure,and we found similar results after IVR+AGV implantation+PRP and IVR+trabeculectomy+PRP in eyes with NVG. 展开更多
关键词 neovascular glaucoma trabeculectomy Ahmed drainage valve implantation ranibizumab panretinal photocoagulation
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部